Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;14(6):497.
doi: 10.1007/s11892-014-0497-x.

Counterpoint: Establishing consensus in the diagnosis of GDM following the HAPO study

H David McIntyre  1 , Boyd E Metzger, Donald R Coustan, Alan R Dyer, David R Hadden, Moshe Hod, Lynn P Lowe, Jeremy J N Oats, Bengt Persson
Affiliations
Review

Counterpoint: Establishing consensus in the diagnosis of GDM following the HAPO study

H David McIntyre et al. Curr Diab Rep. 2014 Jun.

Abstract

The International Association of Diabetes in Pregnancy Study Groups (IADPSG) recommended a new protocol of 1-step testing with a 75 g oral glucose tolerance test for gestational diabetes in 2010. Since that time, these recommendations have been carefully scrutinized and accepted by a variety of organizations, but challenged or rejected by others. In the current review, we present more details regarding the background to the development of the IADPSG recommendations and seek to place them in context with the available epidemiologic and randomized controlled trial data. In this "counterpoint," we also provide specific rebuttal for errors of fact and disputed contentions provided by Long and Cundy in their 2013 article in Current Diabetes Reports.

PubMed Disclaimer

Conflict of interest statement

Compliance with Ethics Guidelines

Conflict of Interest

H. David McIntyre has board membership with the Mater Research Institute. He has received speakers’ fees from Novo Nordisk, Eli Lilly, Sanofi-Aventis, and AstraZeneca. He has received travel/accommodations expenses covered or reimbursed for travel to meetings from Novo Nordisk, Sanofi-Aventis, and AstraZeneca.

Donald R. Coustan has received royalties for textbooks written or edited. He has received honoraria from various academic institutions and professional organizations for lectures given, none from commercial entities. He has received travel expense reimbursement and coverage for giving lectures at various academic institutions and professional organizations, none from commercial entities. He was regional director for North America in the HAPO study.

Boyd E. Metzger, Alan R. Dyer, David R. Hadden, Moshe Hod, Lynn P. Lowe, Jeremy J.N, and Bengt Persson declare that they have no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. - PubMed

    1. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682. This paper presents the recommendations of the IADPSG consensus panel, which form the basis of the current point/counterpoint discussion

    1. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013;36(Suppl 1):S11–S66. - PMC - PubMed
    1. Blumer I, Hadar E, Hadden DR, Jovanovic L, Mestman JH, Murad MH, et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(11):4227–4249. - PMC - PubMed
    1. World Health Organization. Diagnostic Criteria and Classification of Hyperglycaemia First Detected in Pregnancy. Geneva: WHO Press; 2013. - PubMed

Publication types

MeSH terms

LinkOut - more resources